Abstract:HomeRadiologyVol. 271, No. 2 PreviousNext CommunicationsLetters to the EditorIs Volumetric Functional MR Imaging Superior to Current Anatomic Imaging Response Criteria for Hepatocellular Carcinoma after Intraarterial Therapy?Xiao-Dan Ye*, Wen-Tao Li†, Zheng Yuan‡ Xiao-Dan Ye*, Wen-Tao Li†, Zheng Yuan‡ Author AffiliationsDepartment of Radiology, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China*Department of Radiology, Shanghai Cancer Hospital, Fudan University, Shanghai, China†Department of Radiology, Shanghai No. 85 Hospital, 1328 Hua Shan Rd, Shanghai 200032, China‡e-mail: [email protected]Xiao-Dan Ye*Wen-Tao Li†Zheng Yuan‡ Published Online:May 1 2014https://doi.org/10.1148/radiol.14132533MoreSectionsFull textPDF ToolsAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookXLinked In References1. Bonekamp S, Halappa VG, Geschwind JF, et al. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. II. Response stratification using volumetric functional criteria after intraarterial therapy. Radiology 2013;268(2):431–439. Link, Google Scholar2. Yuan Z, Li WT, Peng WJ. Pre-treatment apparent diffusion coefficient is imaging biomarker for prediction of response to chemoembolization in hepatocellular carcinoma. Eur J Radiol 2013;82(12):e901–e902. Crossref, Medline, Google Scholar3. Yuan Z, Ye XD, Dong S, et al. Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma. Eur J Radiol 2010;75(1):e9–e14. Crossref, Medline, Google Scholar4. Dong S, Ye XD, Yuan Z, et al. Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization. Eur J Radiol 2012;81(3):472–477. Crossref, Medline, Google Scholar5. Song MJ, Chun HJ, Song Do S, et al. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol 2012;57(6):1244–1250. Crossref, Medline, Google Scholar6. Sacco R, Bargellini I, Bertini M, et al. Conventional versus doxorubicin-eluting bead transarterial chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol 2011;22(11):1545–1552. Crossref, Medline, Google Scholar7. Kim BK, Kim SU, Kim MJ, et al. Number of target lesions for EASL and modified RECIST to predict survival in hepatocellular carcinoma treated with chemoembolization. Clin Cancer Res 2013;19(6):1503–1511. Crossref, Medline, Google Scholar8. Gillmore R, Stuart S, Kirkwood A, et al. EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol 2011;55(6):1309–1316. Crossref, Medline, Google ScholarArticle HistoryPublished online: May 2014Published in print: May 2014 FiguresReferencesRelatedDetailsCited ByRadiological biomarkers for assessing response to locoregional therapies in hepatocellular carcinoma: From morphological to functional imagingXiao-DanYe, ZuguoYuan, JianZhang, ZhengYuan2017 | Oncology Reports, Vol. 37, No. 3Diffusion-Weighted MR Imaging of Hepatocellular Carcinoma: Current Value in Clinical Evaluation of Tumor Response to Locoregional TreatmentZhengYuan, JianZhang, HuanYang, Xiao-DanYe, Li-ChaoXu, Wen-TaoLi2016 | Journal of Vascular and Interventional Radiology, Vol. 27, No. 1Recommended Articles Imaging Biomarkers of Tumor Response in Neuroendocrine Liver Metastases Treated with Transarterial Chemoembolization: Can Enhancing Tumor Burden of the Whole Liver Help Predict Patient Survival?Radiology2016Volume: 283Issue: 3pp. 883-894Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?Radiology2021Volume: 298Issue: 3pp. 680-692Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular CarcinomaRadiology2019Volume: 292Issue: 1pp. 237-247Early Sorafenib-related Biomarkers for Combination Treatment with Transarterial Chemoembolization and Sorafenib in Patients with Hepatocellular CarcinomaRadiology2017Volume: 284Issue: 2pp. 583-592Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical TranslationRadiology: Imaging Cancer2023Volume: 5Issue: 3See More RSNA Education Exhibits Treatment Response Assessment After Radiation Therapy For Hepatocellular Carcinoma (HCC): Diagnostic ChallengesDigital Posters2021Response Evaluation Criteria in GI Cancers: What to Use and How to Measure: An Emerging Challenge in the Era of Novel Cancer TreatmentsDigital Posters2022To Be Viable Hcc Or Not To Be? ThatâS The QuestionDigital Posters2021 RSNA Case Collection Hepatic AdenomatosisRSNA Case Collection2021LI-RADS 5RSNA Case Collection2022Radioembolization of Liver Metastasis RSNA Case Collection2020 Vol. 271, No. 2 Metrics Altmetric Score PDF download

Clinical course of patients with hepatocellular carcinoma who experienced radiologic complete response after radioembolization

CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma after Surgical Resection

Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma

Local recurrence following a complete radiologic response in hepatocellular carcinoma patients: comparison of transarterial chemoembolisation and transarterial radioembolisation

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis

Early Complete Tumor Response As a Survival Predictor in Hepatocellular Carcinoma Patients Receiving Stereotactic Body Radiation Therapy

Clinical Outcomes of Patients With Unresectable Primary Liver Cancer Treated With Yttrium-90 Radioembolization With an Escalated Dose

Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma

Systemic Chemotherapy Improves Outcome of Hepatocellular Carcinoma Patients Treated with Transarterial Chemoembolization

Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study

Outcomes of Yttrium-90 Radioembolization for Unresectable Combined Biphenotypic Hepatocellular-Cholangiocarcinoma

Long-term complete response after transcatheter arterial chemoembolization and stereotactic body radiation therapy in a patient with hepatocellular carcinoma at the caudate lobe

Early Intrahepatic Recurrence of Hepatocellular Carcinoma after Hepatectomy Treated with Re-Hepatectomy, Ablation or Chemoembolization: a Prospective Cohort Study.

Influence of the Radiological Response on Histological Necrosis and on the Survival of Patients Treated With Transarterial Chemoembolization for Hepatocellular Carcinoma Secondary to Cirrhosis on the Liver Transplantation Waiting List

Depth of Radiographic Response As an Independent Prognostic Factor for Patients with Initially Unresectable Hepatocellular Carcinoma Receiving Hepatectomy Following Targeted Therapy Plus Immunotherapy

Radiological response as a predictor of pathological response to combined tyrosine kinase inhibitor (TKI) and anti-PD-1 antibodies in hepatocellular carcinoma (HCC).

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

Pattern of Retained Contrast on Immediate Postprocedure Computed Tomography (CT) after Particle Embolization of Liver Tumors Predicts Subsequent Treatment Response

Is Volumetric Functional MR Imaging Superior to Current Anatomic Imaging Response Criteria for Hepatocellular Carcinoma after Intraarterial Therapy?

Longitudinal assessment of hepatocellular carcinoma response to stereotactic body radiation using gadoxetate-enhanced MRI: A case series

A Comparison of Chemoembolization Combination with and Without Radiotherapy for Unresectable Hepatocellular Carcinoma